clinical trial · NCT00398151
To Evaluate the Inflammatory Markers in Adult Patients With Asthma Associated With Allergic Rhinitis Receiving Montelukast Therapy (0476-366)
Organon and Co·phase3·completed·n = 58
AsthmaMK0476, montelukast sodium / Duration of Treatment: 12 Weeks
brief summary
To evaluate the changes in proinflammatory markers (ltd4 in urine) and eosinophil from peripheral blood after newly initiated montelukast therapy.
started
Aug 1, 2005
primary completion
Jan 18, 2006
completion
Jan 18, 2006
last updated
Aug 15, 2024
official title
An Open-Label Study to Evaluate the Inflammatory Markers in Adult Patients With Asthma Associated With Allergic Rhinitis Receiving Montelukast Therapy
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol